| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/07/2009 | US20090118221 Method of treating arrhythmias |
| 05/07/2009 | US20090118217 Using presence of single nucleotide polymorphism in apopoliprotein gene sequences as diagnostic indicator of cardiovascular disorders |
| 05/07/2009 | US20090118208 Composition and methods of RNAI therapeutics for treatment of cancer and other neovascularization diseases |
| 05/07/2009 | US20090118202 Compositions and methods of treating hypertension with tannin complexes |
| 05/07/2009 | US20090118182 Fibroblast Growth Factor-Like Polypeptides |
| 05/07/2009 | US20090118160 Heterocyclic compounds and methods of use |
| 05/07/2009 | US20090117639 Neural Progenitor Cell Populations |
| 05/07/2009 | US20090117207 Methods and compositions for treatment of poison-caused pathology |
| 05/07/2009 | US20090117196 A method for embolization by administering crosslinked polyvinylalcohol microspheres substantially spherical, sterile, and having any excess aldehyde on surfaces neutralized by an aminoalcohol; antitumor agents; hemostatic agents; analgesics; surgery; biocompatability; nontoxic; antiagglomerants |
| 05/07/2009 | US20090117194 Eukaryotic microorganisms for producing lipids and antioxidants |
| 05/07/2009 | US20090117193 Compositions Comprising an Active Agent |
| 05/07/2009 | US20090117137 Peptide epitopes of apolipoprotein b |
| 05/07/2009 | US20090117133 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW AFFINITY FCyRECEPTORS |
| 05/07/2009 | US20090117090 Inhibition of glycogen synthase kinase 3 beta in arterial repair and stent re-endothelialization |
| 05/07/2009 | US20090117039 Charged biodegradable polymers for medical applications |
| 05/07/2009 | US20090117033 Injectable biodegradable particles |
| 05/07/2009 | DE102007051762A1 Substituierte Pyrrolotriazine und ihre Verwendung Substituted Pyrrolotriazine and their use |
| 05/07/2009 | CA2742345A1 Hyperbranched polyglycerol for improving heart function |
| 05/07/2009 | CA2704627A1 Compositions for tissue repair/regeneration |
| 05/07/2009 | CA2704246A1 Chimeric relaxin polypeptides comprising an a and b chain derived from different relaxin family peptides |
| 05/07/2009 | CA2703838A1 Diagnostic and therapeutic methods and compositions for cardiovascular disease |
| 05/07/2009 | CA2703770A1 Uses of a glycoprotein vi (gpvi) inhibitor |
| 05/07/2009 | CA2702755A1 Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes |
| 05/07/2009 | CA2695628A1 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors |
| 05/06/2009 | EP2055716A1 Kallikrein-inhibiting "Kunitz Domain" proteins and nucleic acids encoding the same |
| 05/06/2009 | EP2055705A1 Compound having cyclic group bound thereto through spiro binding and use thereof |
| 05/06/2009 | EP2055703A1 Novel pyrimidine compound having benzyl(pyridylmethyl)amine structure and pharmaceutical comprising the compound |
| 05/06/2009 | EP2055696A1 Acid addition salts of mandelic acid derivatives |
| 05/06/2009 | EP2055308A1 Pharmaceutical for promoting functional regeneration of damaged tissue |
| 05/06/2009 | EP2055301A1 Solid oral dosage forms comprising valsartan |
| 05/06/2009 | EP2054424A1 Vinyl phosphonate lysophosphatidic acid receptor antagonists |
| 05/06/2009 | EP2054417A2 Fused thiophene derivatives as mek inhibitors |
| 05/06/2009 | EP2054392A2 2-anilino-4-(heterocyclic)amino-pyrimidines as inhibitors of protein kinase c-alpha |
| 05/06/2009 | EP2054389A1 6-substituted isoquinoline derivatives as rock-1 inhibitors |
| 05/06/2009 | EP1599453B1 3-methyl-2- (3- (2-phenyl-oxazol-4-ylmethoxy)-cyclohexanecarbonyl-amino butyric acid derivatives and related compounds as ppar modulators for the treatment of type 2 diabetes and atherosclerosis |
| 05/06/2009 | EP1443961B1 Glycoprotein compositions |
| 05/06/2009 | EP1373265B1 Substituted 2,6-diamino-3,5-dicyano-4-aryl-pyridines and their use as adenosine receptor-selective ligands |
| 05/06/2009 | EP1343782B1 Pyrimidineamines as angiogenesis modulators |
| 05/06/2009 | EP1308440B1 Piperidine derivatives and drugs containing these derivatives as the active ingredient |
| 05/06/2009 | EP1242082B1 Methods and compositions for the prevention and treatment of atherosclerosis, restenosis and related disorders |
| 05/06/2009 | EP1235562B1 Chronotherapeutic diltiazem formulations and the administration thereof |
| 05/06/2009 | EP1200114B1 Ppar delta inhibitors for the treatment of cardiovascular diseases |
| 05/06/2009 | EP1173155A4 Gum pad for delivery of medication to mucosal tissues |
| 05/06/2009 | EP1152750B1 Spontaneously dispersible n-benzoyl staurosporine compositions |
| 05/06/2009 | CN101426792A Pyrazolopyrimidines as therapeutic agents |
| 05/06/2009 | CN101426783A Cyclohexylpyrazole-lactam derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 05/06/2009 | CN101426772A Benzotriazine inhibitors of kinases |
| 05/06/2009 | CN101426768A Sulfonamide compounds useful as adg receptor modulators |
| 05/06/2009 | CN101426763A Sulfide and disulfide compounds and compositions for cholesterol management and related uses |
| 05/06/2009 | CN101426483A Purine derivatives as A2A receptor agonists |
| 05/06/2009 | CN101426482A Purine derivatives for use as adenosin A2A receptor agonists |
| 05/06/2009 | CN101426480A Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion |
| 05/06/2009 | CN101426477A Nanoparticulate carvedilol formulations |
| 05/06/2009 | CN101423537A Scutellarin and medical use thereof |
| 05/06/2009 | CN101423518A Imidazole derivates and medical use thereof |
| 05/06/2009 | CN101423500A Substituted benzoxazoles and analogues as estrogenic agents |
| 05/06/2009 | CN101422612A Method for increasing crocetin water solubility |
| 05/06/2009 | CN101422595A Traditional Chinese medicine composition for treating dizziness and preparation method and quality control method thereof |
| 05/06/2009 | CN101422594A Traditional Chinese medicine composition and preparation method thereof |
| 05/06/2009 | CN101422562A Medicine for treating premature beat and atrial fibrillation |
| 05/06/2009 | CN101422536A Preparation method of traditional Chinese medicine for treating excessive-heat intestinal dryness type internal hemorrhoid |
| 05/06/2009 | CN101422506A Prescription for treating varicosis |
| 05/06/2009 | CN101422497A Ginsenoside Rb1 containing impurity Panax Notoginseng saponin R2 |
| 05/06/2009 | CN101422492A Use of nano gingko liquid |
| 05/06/2009 | CN101422473A Use of ginsenoside Rb1 |
| 05/06/2009 | CN101422462A Use of ligustrazine phosphate in preparing medicine for treating dilated cardiomyopathy |
| 05/06/2009 | CN101422459A Atenolol/nitrendipine/folic-acid compound medicine combination and use thereof |
| 05/06/2009 | CN101422456A Medicine combination drop-pills and preparation method and quality detection method thereof |
| 05/06/2009 | CN101422454A Omega-3 polyunsaturated fatty acid tanshinone IIA sub-microemulsion and preparation method thereof |
| 05/06/2009 | CN101422453A Verapamil hydrochloride delayed-release capsule and preparation method thereof |
| 05/06/2009 | CN101422447A Instant film preparation containing phenylephrine hydrochloride |
| 05/06/2009 | CN101422440A Hydrochlorothiazide-metroprolol succinate sustained-release drop pills and preparation method thereof |
| 05/06/2009 | CN101422241A Antihypertensive health-care porridge |
| 05/06/2009 | CN101422238A Hypertension paste |
| 05/06/2009 | CN100485035C Novel scavenger albumen receptors |
| 05/06/2009 | CN100485021C Natural animal essence muskrat fragrant active component, preparation technology and its use |
| 05/06/2009 | CN100484963C Exo-polysaccharide of lactobacillus casei and crude product, prepartion method and application |
| 05/06/2009 | CN100484957C Thymosin beta4 derivative and its use |
| 05/06/2009 | CN100484953C Pseudoginsenoside-Pdq and its semi-synthesis process and medicine use |
| 05/06/2009 | CN100484936C Synthesis of (2S,6R)-6-amino-2(2-thienyl)1,4-parathiazine-5-ketone |
| 05/06/2009 | CN100484934C Processes for preparing substituted pyrimidines and pyrimidine derivatives as inhibitors of protein kinase |
| 05/06/2009 | CN100484929C Rod sage root extract and making method of its preparation |
| 05/06/2009 | CN100484569C Medicament for mobilizing pluripotent stem cells from tissue into peripheral blood |
| 05/06/2009 | CN100484564C Medicine for treating hypertension |
| 05/06/2009 | CN100484563C Chinese medicine composition for treating cardiovascular and cerebrovascular diseases and preparation method thereof |
| 05/06/2009 | CN100484558C Ginseng freeze-drying powdery injection and its quality control method |
| 05/06/2009 | CN100484557C Chinese medicine compound preparation for treating myocardial ischemia and improving microcirculation, and preparing method thereof |
| 05/06/2009 | CN100484529C Cardiac and cerebral vascular disease treating medicinal composition |
| 05/06/2009 | CN100484517C Smash-resisting panax notoginseng total saponin free-dried powdery injection and its preparation |
| 05/05/2009 | US7528252 Derivatives of triazoly-imidazopyridine useful as ligands of the adenosine A2a receptor and their use as medicaments |
| 05/05/2009 | US7528162 such as 3-(4-Chlorophenyl)-N'-((4-chlorophenyl)sulfonyl)-N-(piperidin-1-yl)-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboxamidine, used as cannabinoid (CB1) receptor antagonists, for prophylaxis of psychological disorders |
| 05/05/2009 | US7528154 Polyarylcarboxamides useful as lipid lowering agents |
| 05/05/2009 | US7528152 synthetic analog of Hemiasterlin; anticarcinogenic agent; restenosis of blood vessels subject to traumas such as angioplasty and stenting; safe and effective, while retaining stability in biological media; exhibit low cytotoxicity to non-dividing normal cells |
| 05/05/2009 | US7528137 Compounds, compositions, and methods |
| 05/05/2009 | US7528124 1,3-dihydro-2H-indol-2-one derivative |
| 05/05/2009 | US7527974 Preparing embryonic stem cells via nuclear transplantation; tissue engineering and the use of embryonic stem in diagnosis, prevention and treatment of cell proliferative, nervous system, muscular and bone disorders; tissue repair |
| 05/05/2009 | US7527946 Angiogenesis and neovascularization inhibition; host cells, recombinant DNA; increased half life and longer vasculature retention time |
| 05/05/2009 | CA2386230C Modulators of cytokine mediated signalling pathways and integrin .alpha.v.beta.3 receptor antagonists for combination therapy |
| 05/05/2009 | CA2267247C Heteroaryloxyethylamines as 5-ht1a ligands |
| 05/05/2009 | CA2234980C Cyclopeptide derivatives |